IOBENGUANE (123I) , [18F]meta-fluorobenzylguanidine
PS22PET
Phase 2 small_molecule active
Quick answer
IOBENGUANE (123I) , [18F]meta-fluorobenzylguanidine for (suspision on) Neuroblastoma is a Phase 2 program (small_molecule) at AXIM BIOTECHNOLOGIES, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- AXIM BIOTECHNOLOGIES, INC.
- Indication
- (suspision on) Neuroblastoma
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active